Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 317,373 |
|
|||||
| News | - | ||||||
| Day High | 4.9782 | Low High |
|||||
| Day Low | 4.73 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| AC Immune SA | ACIU | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.07 | -1.44% | 4.80 | 23:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.91 | 4.73 | 4.9782 | 4.77 | 4.87 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,900 | 317,373 | US$ 4.86 | US$ 1,543,936 | - | 1.90 - 5.14 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:29:58 | formt | 200 | US$ 4.80 | USD |
AC Immune SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 472.18M | 99.20M | - | 3.94M | -70.75M | -0.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AC Immune News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACIU Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.31 | 4.95 | 4.2298 | 4.74 | 629,085 | 0.49 | 11.37% |
| 1 Month | 2.35 | 4.95 | 2.29 | 3.44 | 2,322,209 | 2.45 | 104.26% |
| 3 Months | 3.30 | 4.95 | 2.25 | 3.32 | 908,077 | 1.50 | 45.45% |
| 6 Months | 3.55 | 5.14 | 2.25 | 3.40 | 502,312 | 1.25 | 35.21% |
| 1 Year | 2.29 | 5.14 | 1.90 | 3.36 | 513,082 | 2.51 | 109.61% |
| 3 Years | 6.30 | 12.61 | 1.68 | 5.47 | 451,981 | -1.50 | -23.81% |
| 5 Years | 5.02 | 14.89 | 1.68 | 6.17 | 426,246 | -0.22 | -4.38% |
AC Immune Description
| AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. |
